Biotech investors up big amid bubble talk – CNBC.com

Others note continued opportunity in biotech.Robert Christian, who analyzes hedge funds as head of research at K2 Advisors and Franklin Templeton Solutions, said biotech stock-focused managers stand out as one of his favorite strategies among the few dozen he tracks.Christian’s optimism rests on what he called exciting new technologies that justify higher company valuations.”Biotech used to be about making life¬†[…]